key: cord-0998095-w8ub1h9x
authors: Naemi, Fatmah M.A.; Al-adwani, Shurooq; Al-khattabi, Heba; Al-nazawi, Ashwaq
title: Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia
date: 2021-05-06
journal: Virology
DOI: 10.1016/j.virol.2021.04.011
sha: 9a3c74b96ff108bec3a6bc3117f8efaf59602dae
doc_id: 998095
cord_uid: w8ub1h9x

HLA polymorphism is one of the genetic factors that may be associated with variations in susceptibility to COVID-19 infection. In this study, the frequency of HLA alleles among Saudi patients infected with COVID-19 was examined. The association with infection susceptibility and mortality was evaluated. This study included 135 Saudi COVID-19-infected patients (106 recovered and 29 died) who were admitted to hospitals because of their symptoms, and 135 healthy controls. HLA class I (A, B, C) and class II (DRB1, DQB1) genotyping was performed using the molecular method (PCR-rSSO). In this study, there was a significant increase in the frequency of HLA-A*01, B*56 and C*01 among infected patients compared to the control group (12.1% vs. 5.2%, p = 0.004, 3.7% vs. 0%, p = 0.006, 4.4% vs. 1.5%, p = 0.042, respectively). Moreover, there was a significant increase in the frequency of HLA-A*03 and C*06 among fatal patients compared to infected patients (13.8% vs. 5.7%, p = 0.036, 32.8% vs. 17.5%, p = 0.011, respectively). In terms of HLA class II, HLA-DRB1*04 was significantly higher in the control group compared to infected patients (27.4% vs. 16.3%, p = 0.002), while HLA-DRB1*08 was significantly higher in the infected group compared to the control (4.8% vs. 0.7%, p = 0.004). After statistical correction of the p value, A*01, B*56, DRB1*04 and DRB1*08 remained statistically significant (p(c) = 0.04, p(c) = 0.03, p(c) = 0.014 and p(c) = 0.028). This initial data suggested that individual HLA genotypes might play a role in determining susceptibility to COVID-19 infection and infection outcome. However, examining a larger sample size from different populations is required to determine a powerful association for clinical application.

A novel β-coronavirus strain which was identified in Wuhan, China in December 2019 caused more than 30 million infections and in excess of one million deaths by October 2020 (https://www.worldometers.info/coronavirus/). The new virus, called Severe Acute Respiratory Syndrome coronavirus-2 (SARS-COV2), mainly infects the respiratory system, causing flu-like symptoms and acute respiratory distress in mild cases. In severe cases, multi-organ dysfunction and death can occur [1] . The virus showed different geographical distributions, with significantly more cases and deaths reported in some areas compared to others. Additionally, there were variations in the severity of the infection between different individuals, with some patients experiencing mild or even no symptoms, while others needed intensive care support [1] . The most affected areas were America with more than 16 million cases, followed by Asia with more than 10 million cases and Europe with more than 6 million cases reported by 1 October 2020. In this report, India was the most affected country in Asia with more than 6 million cases reported, while J o u r n a l P r e -p r o o f the lowest number of cases was in Saudi Arabia (<500,000 cases) (https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-ca s). Although different factors such as age, comorbidity, and adaptive immunity might play a role in viral infections, genetic factors have a fundamental role in determining individuals' susceptibility to any infectious agents [2] .

Human Leukocyte Antigen (HLA) molecules have been extensively studied as a genetic factor that might affect virus progression or resistance [3, 4] . Because of the role of HLA molecules in antigen presentation, host immune response will vary according to the selected peptide presented by individual HLA molecules. The interaction between the HLA/peptide complex and Tlymphocytes can induce an efficient immune response to eradicate the virus, while other interactions might induce weak T-lymphocyte activation leading to infection progression [4] .

Therefore, HLA polymorphism between individuals or populations can have a role in the response to certain viruses. In other words, viruses which might be fatal to certain populations may be less severe in others depending on their genetic variance and the type of HLA molecules.

Many research groups have studied the association between HLA genotypes and respiratory viral infections, however no definite association has been identified between a specific HLA type and susceptibility to viral infection [5, 6] , [7] . This could be attributed to the small sample size of these studies or to polymorphism of HLA alleles, where more than one antigen might be involved in infection susceptibility for certain populations. In this study, the frequency of HLA class I (A, B, C) and HLA class II (DR, DQ) alleles between Saudi COVID-19-positive patients was examined. The positive group was divided into infected but recovered patients and fatal patients, and these were compared to a control group. To our knowledge, this is the first study from an Arab country to consider the association between HLA genotypes and COVID-19 infection susceptibility and mortality. 

The control and infected groups were tested for Hardy-Weinberg equilibrium using Guo and Thomson method implemented in Pypop (www.pypop.org) [8] .

Absolute count and percentage were applied to describe allele frequency. Arithmetic mean and standard deviation were used to describe continuous variables (e.g. age). The chi-squared test was applied to test for the association between two categorical variables. Fisher's exact test was performed in case of having a frequency of less than 5 in one or more of the cells. One-way analysis of variance and post-hoc Tukey's test were applied to compare the mean of and between the three compared groups. Statistical significance was determined at p<0.05. Statistical analyses were performed using the Statistical Package for Social Sciences, version 25 software. The

Bonferroni correction was applied to the p value and calculated by multiplying by the number of alleles with a frequency >5%. Relative risks with corresponding 95% confidence intervals (95% CI) were calculated according to Woolf's formula [9] . Relative risks <1 indicated protection while >1 indicated an increased risk. differences among the three groups with respect to gender distribution, as shown in Figure 1 .

However, COVID-19 infection showed a male preference as 70% of the infected group was male.

The ages of subjects in the control group were significantly lower than the infected patients group (p=0.038) and the fatal group (p=0.001), with no statistical significance between the infected and fatal groups. Additionally, HLA-A*26 was significantly higher in the control group compared to the infected group (p=0.021). On the other hand, the frequency of HLA-A*03 was higher among the fatal group than the infected group (13.8% vs. 5.7%, p=0.036). The frequency of this allele was not significant between the control and infected groups or between the control and fatal groups (p=0.871, p=0.143, respectively). After Bonferroni correction, the differences in these alleles between groups were non-significant. J o u r n a l P r e -p r o o f 

From In the fatal group, the most common alleles were DQB1*02 (29.3%), DQB1*03 (22.4%), DQB1*05 (20.7%) and DQB1*06 (20.7%). There were no statistical differences in the frequency of HLA-DQB1 between groups. Table 5 shows the frequency of HLA-DQB1 between different groups. 

The risks associated with the identified alleles and increased incidence of infection were determined, see Table 6 . The relative risk was calculated using the most common HLA in the control group as a reference. Compared to A*02, participants with A*01 were at significant risk of being infected (relative risk "RR"=1.47, 95% CI: 1.14- 

The COVID-19 pandemic is still causing a significant number of cases worldwide with a stable rate of mortality not exceeding 7% [10] . The infection is creating pressure on an economic level due to business disruptions and the burden on healthcare institutions. The virus has spread to most countries at different rates of infection, with some countries reporting thousands of cases daily while others are reporting no more than one thousands cases in total (https://covid19.who.int/). Differences in the rate of infection between different geographical regions cannot be fully understood. HLA polymorphism, with more than 20,000 alleles identified for classical HLA class I and 7000 alleles identified for HLA class II, is one of the genetic factors that may affect individuals' susceptibility or resistance to COVID-19 infection (https://www.ebi.ac.uk/ipd/imgt/hla/stats.html). Previous studies have shown an association between HLA alleles and susceptibility to various viral infections such as hepatitis, HIV, and respiratory infections [11] [12] [13] [14] . There is conflicting data on the association between HLA and respiratory viral infections. Some studies have shown a positive correlation between classical HLA loci and previous respiratory infections such as Severe Acute Respiratory Syndrome

Taiwanese patients infected with SARS-COV1 showed that the HLA-B*46:01 genotype was common among infected patients [3] . On the other hand, another study showed that patients with HLA-C*15 and HLA-DRB1*03 genotypes were more resistant to SARS infection [5] .

Furthermore, a study from China again showed no HLA contribution to the incidence of SARS infection [15] .

In this study, the genotype frequency of HLA, both class I and class II, was identified in a respectively. The frequency of these antigens is less common in the Saudi population. Previous HLA data analysis of HLA allele frequencies from the Saudi bone marrow registry showed that the frequency of A*01 was around 7.1%, the frequency of HLA-A*03 was around 5.9% of the registered donors and the frequency of HLA-B*56 was low with a frequency reaching to 0.0007 [16] . Similar allele frequencies of these two alleles were reported by another group analysed the HLA allele frequencies of 45,457 stem cell registered donors [17] . The most common specific alleles which were reported among Saudi population were A*01:01, A*01:03, HLA-A*03:01/02 and B*56:01 [16, 17] . In other Arab populations, the frequency of HLA-A*01 ranged from 15%

(Tunisians) to 6% in some Arab populations (Emirates). On the other hand, the frequency of the HLA-A*03 allele was estimated to be 15% in the Iranian population and ranging to 6% in other Arab populations [18] . These allele frequencies might be in parallel with our results, in which the [25] . However, these studies lack a sufficient number of cases to make a significant conclusion. This may cause variations in the results between studies. In our cohort, there was no significant difference in the frequency of HLA-A*24 between the control and infected groups. However, HLA-A*24 was significantly lower in the fatal group compared to the infected group (recovered) with insignificant p value after correction. Interestingly, a recent in-silico study reported the HLA-A*24 specific allele as an allele associated with efficient T-cell anti-viral response leading to virus eradication [26] . The involvement of this allele in COVID-19 recovery might be elucidated by examining more patients.

In this study, there was a significant difference in the frequency of HLA-C between groups. There was a significant decrease in the frequency of HLA-C*04 in the fatal group compared to the infected group, while a significant increase was seen in the frequency of HLA-C*06 in the fatal group compared to the infected group. Additionally, we reported a significant increase in the frequency of HLA-C*01 in the infected group compared to the control group. However, these results were non-significant after p value correction. A larger sample size in the future might elucidate this association clearly. A recent epidemiological study from Italy concluded that HLA-C*01 might be a genetic factor responsible for the variations in susceptibility to infection between different regions in Italy [27] . HLA-C loci is well known as a ligand for killer immunoglobulin-like receptors (KIR) on natural killer cells [28] . The interaction of a certain HLA-C/peptide complex with certain KIR is associated with inhibition of NK cell cytotoxic activity to target infected cells. In other viral infectious diseases, an association between HLA-C*04 and a KIR subset allele was associated with an increase in viral load and infection progression [29] . The frequency of HLA-C alleles in infected and fatal groups might be associated with a disturbance in the activity of the natural killer cells as described previously with other viral infections [30] . However, this hypothesis will not be confirmed unless KIR genotyping is performed, which can be investigated in another study.

In this study, there was a significant increase in the frequency of HLA-DRB1*04 in the control group compared to the infected group with insignificant corrected p value. There was a significant increase in the frequency of HLA-DRB1*08 in the infected group compared to the control group, which remained significant after p value correction and was associated with a relative risk 2.32. The most common specific alleles reported in Saudi population were DRB1*04:01 (0.011) followed by DRB1*04:04 and DRB1*04:06 (0.0067). While the most common HLA-DRB1*08 alleles were DRB1*08:04 (0.013) followed by DRB1*08:03 (0.002) J o u r n a l P r e -p r o o f with low frequencies in both DRB1*08:02 and 08:06 (0.0002) [16] . Although HLA class I is well known as a molecule that presents intracellular molecules, HLA class II can have a role in viral peptide presentation. A recent study showed that peptides from SARS-COV2 can bind HLA-DR molecules present on monocytes [31] . Furthermore, differences in HLA class II frequency were also reported in a study from Italy with a cohort of 99 COVID-19-infected patients, in which an association between HLA-DRB1*15:01, DQB1*06:02 and B*27:07 and the incidence of COVID-19 infection was suggested [32] . As mentioned earlier, a lack of consistency between studies might be attributed to sample size and population variations. In this study, we can show that certain HLA alleles, such as HLA-A*01, might be associated with increased incidence of infection by SARS-COV2, and certain alleles were observed only in the infected group, such as B*56, in addition to alleles identified mainly in the fatal group, such as HLA-A*03. However, these initial results need exploring with larger sample sizes from different regions and probably with higher resolution of typing.

In conclusion, individual HLA genotypes may be associated with susceptibility to COVID-19

infection and infection outcome. Examining a larger sample size and samples from different populations might identify a powerful association, which can be used as a risk factor in a screening protocol. 

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

Covid-19: risk factors for severe disease and death

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

HLA and infectious diseases

Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection

Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population

Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501. Acta crystallographica. Section F, Structural biology and crystallization communications

Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies

On estimating the relation between blood group and disease

A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. The Journal of infection

Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection

The immunogenetics of human infectious diseases

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes

Lack of association between HLA-A,-B and-DRB1 alleles and the development of SARS: A cohort of 95 SARS-recovered individuals in a population of Guangdong, Southern China

DRB1 -DQB1 and -DPB1 Allele and Haplotype Frequencies of 28927 Saudi Stem Cell Donors Typed by Sequencing

High-resolution HLA allele and haplotype frequencies of the Saudi Arabian population based on 45,457 individuals and corresponding stem cell donor matching probabilities

The genetic heterogeneity of Arab populations as inferred from HLA genes

High-resolution analysis of the HLA-A, -B, -C and -DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry. HLA

The distribution of HLA haplotypes in the ethnic groups that make up the Brazilian Bone Marrow Volunteer Donor Registry (REDOME)

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

In silico identification of vaccine targets for 2019-nCoV

Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients

HLA predictions from the bronchoalveolar lavage fluid samples of five patients at the early stage of the wuhan seafood market COVID-19 outbreak

Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019

Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis. Immunity, Inflammation and Disease

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy

Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression

HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. EBioMedicine

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells

The authors would like to thank Science and Technology Unit, Ministry Of Health, Kingdome of Saudi Arabia for their assistance. Many thanks to Dr. Howell Martin for his feedback.Conflicts of Interest: "The authors declare no conflict of interest."

J o u r n a l P r e -p r o o f

 Genetic polymorphism plays a role in the susceptibility to COVID-19  HLA polymorphism between populations might be responsible for the variations in the susceptibility to SARS-COV2 infection  There was a predominance in the frequency of HLA class I alleles in the COVID-19 positive group compared to control group  HLA polymorphism might be associated with infection related mortality